MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer

Targeted therapy for metastatic diseases relies on the identification of functionally important metastasis genes from a large number of random genetic alterations. Here we use a computational algorithm to map minimal recurrent genomic alterations associated with poor-prognosis breast cancer. 8q22 ge...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hu, Guohong, Chong, Robert A., Yang, Qifeng, Wei, Yong, Blanco, Mario A., Li, Feng, Reiss, Michael, Au, Jessie L. –S., Haffty, Bruce G., Kang, Yibin
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2676231/
https://ncbi.nlm.nih.gov/pubmed/19111877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2008.11.013
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items